ResMed Inc (RMD)
243.78
+0.18
(+0.07%)
USD |
NYSE |
Nov 22, 16:00
246.38
+2.60
(+1.07%)
Pre-Market: 07:03
ResMed Debt to Equity Ratio: 0.1304 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.1304 |
| June 30, 2024 | 0.1454 |
| March 31, 2024 | 0.2175 |
| December 31, 2023 | 0.2737 |
| September 30, 2023 | 0.3203 |
| June 30, 2023 | 0.349 |
| March 31, 2023 | 0.4033 |
| December 31, 2022 | 0.4817 |
| September 30, 2022 | 0.2317 |
| June 30, 2022 | 0.2307 |
| March 31, 2022 | 0.2076 |
| December 31, 2021 | 0.2162 |
| September 30, 2021 | 0.2662 |
| June 30, 2021 | 0.2271 |
| March 31, 2021 | 0.2698 |
| December 31, 2020 | 0.2882 |
| September 30, 2020 | 0.3944 |
| June 30, 2020 | 0.471 |
| March 31, 2020 | 0.6102 |
| December 31, 2019 | 0.5755 |
| September 30, 2019 | 0.5763 |
| June 30, 2019 | 0.6133 |
| March 31, 2019 | 0.6608 |
| December 31, 2018 | 0.6122 |
| September 30, 2018 | 0.2787 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.1367 |
| March 31, 2018 | 0.3919 |
| December 31, 2017 | 0.5046 |
| September 30, 2017 | 0.4971 |
| June 30, 2017 | 0.5502 |
| March 31, 2017 | 0.6299 |
| December 31, 2016 | 0.6833 |
| September 30, 2016 | 0.6618 |
| June 30, 2016 | 0.692 |
| March 31, 2016 | 0.2603 |
| December 31, 2015 | 0.2635 |
| September 30, 2015 | 0.3427 |
| June 30, 2015 | 0.1894 |
| March 31, 2015 | 0.2998 |
| December 31, 2014 | 0.2831 |
| September 30, 2014 | 0.2273 |
| June 30, 2014 | 0.1711 |
| March 31, 2014 | 0.2341 |
| December 31, 2013 | 0.2659 |
| September 30, 2013 | 0.2132 |
| June 30, 2013 | 0.1868 |
| March 31, 2013 | 0.1928 |
| December 31, 2012 | 0.1718 |
| September 30, 2012 | 0.1565 |
| June 30, 2012 | 0.156 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1304
Minimum
Sep 2024
0.6102
Maximum
Mar 2020
0.3155
Average
0.2717
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.5254 |
| Globus Medical Inc | 0.1074 |
| Haemonetics Corp | 1.394 |
| Abbott Laboratories | 0.3764 |
| Merit Medical Systems Inc | 0.5671 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.222B |
| Total Liabilities (Quarterly) | 2.027B |
| Shareholders Equity (Quarterly) | 5.195B |
| Current Ratio | 2.921 |
| Net Debt Paydown Yield | 0.43% |